Article
IGFBP1 and IGFBP3 polymorphisms predict circulating IGFBP-3 levels among women from high-risk breast cancer families.
Breast cancer research and treatment - 1 Jun 2011
Rosendahl Ann H, Hietala Maria, Henningson Maria, Olsson Håkan, Jernström Helena
Abstract excerpt
The insulin-like growth factor (IGF) pathway has been implicated as risk modifier in premenopausal breast cancer. In this study, associations between single nucleotide polymorphisms (SNPs) and diplotypes in the IGFBP1 and IGFBP3 genes and circulating IGFBP-3 levels, BRCA family status and breast cancer among women from high-risk breast cancer families were investigated. Nine IGFBP1 and IGFBP3 SNPs were genotyped...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
